Dr. Donna Kimbark discusses CDMRP’s unique non-dilutive funding opportunities for cancer R&D.

Dr. Akua Roach discusses non-dilutive funding opportunities through CDMRP.

Dr. William Bozza discusses non-dilutive funding opportunities at NCI and NIH.

Dr. Charles L. Cywin discusses non-dilutive funding opportunities at NINDS and NIH.

Dr. Daniel Gossett discusses non-dilutive funding opportunities at NIDDK and NIH.

Dr. Abla Creasey discusses non-dilutive funding opportunities at the California Institute for Regenerative Medicine, which funds stem cell R&D.

Nick Damiano, co-founder and CEO of Abalone Bio, discusses the company’s success with non-dilutive funding. Abalone Bio is the first company to win funding from FreeMind Investments.

Nick Damiano, co-founder and CEO of Zenflow, discusses the company’s success with non-dilutive funding.

Tim Sweeney, MD, PhD, is co-founder and CEO of Inflammatix, discusses the company’s success with non-dilutive funding.